Zagam Respipac and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Zagam Respipac (sparfloxacin).
multivitamins with minerals sparfloxacin
Moderate Drug Interaction
Sparfloxacin and multivitamin with minerals should not be taken orally at the same time. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of sparfloxacin into the bloodstream and reduce its effectiveness. If possible, it may be best to avoid taking multivitamin with minerals while you are being treated with sparfloxacin. Otherwise, sparfloxacin should be taken 2 to 4 hours before or 4 to 6 hours after a multivitamin with minerals dose, sparfloxacin should be taken at least 2 hours before and not less than 6 hours after Suprep Bowel Prep (magnesium/potassium/sodium sulfates), or sparfloxacin and multivitamin with minerals should be taken as directed by your healthcare provider. Talk to your healthcare provider if you are unsure whether your medications contain something that could potentially interact or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Zagam Respipac drug interactions
There are 471 drug interactions with Zagam Respipac (sparfloxacin).
Zagam Respipac disease interactions
There are 9 disease interactions with Zagam Respipac (sparfloxacin) which include:
- colitis
- CNS disorders
- myasthenia gravis
- peripheral neuropathy
- tendonitis
- QT interval prolongation
- crystalluria
- diabetes
- renal dysfunction
Report options
More about Zagam Respipac (sparfloxacin)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: quinolones and fluoroquinolones
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
